Business Context and Reporting Period
Hims & Hers Health, Inc. filed a Form 8-K reporting a board appointment. The earliest reported event occurred on April 24, 2024; the filing was signed on April 26, 2024. This filing does not report quarterly or annual operating results.
Material Corporate Change
- The board increased from ten to eleven directors.
- Anja Manuel, age 49, was appointed effective April 24, 2024, to serve until the 2024 annual meeting and until her successor is elected and qualified, or earlier departure.
- The board determined that Ms. Manuel is independent under applicable New York Stock Exchange and Securities Exchange Act requirements.
- She had not been appointed to any board committees as of the filing.
- She will receive compensation under the company’s director compensation program and enter into the company’s standard indemnification agreement.
Financial Metrics, Guidance, and Risks
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, financial guidance, or other operating metrics. It also does not disclose specific risk factors, contingencies, or unusual financial items.
Other Governance Disclosures
- The company reported no arrangements or understandings supporting Ms. Manuel’s election.
- No family relationships with directors, executive officers, or nominees were reported.
- No related-party transaction requiring disclosure under Item 404(a) of Regulation S-K was reported.
Investor Verification Items
- Confirm Ms. Manuel’s continuing service and committee assignments following the 2024 annual meeting.
- Review the company’s proxy statement filed April 26, 2024, for director compensation and additional information about the appointment.
- Consult separate earnings or periodic filings for financial performance, liquidity, leverage, guidance, and business risks, as these matters are not covered in this Form 8-K.